The clinical translation of eicosanoids and other oxylipins, although challenging, should be actively pursued

Cécile Gladine; Maria Fedorova

doi:10.1016/j.jmsacl.2021.08.003

The clinical translation of eicosanoids and other oxylipins, although challenging, should be actively pursued

J Mass Spectrom Adv Clin Lab. 2021 Aug 25:21:27-30. doi: 10.1016/j.jmsacl.2021.08.003. eCollection 2021 Aug.

Authors

Cécile Gladine¹, Maria Fedorova^{2

3}

Affiliations

¹ Université Clermont Auvergne, INRAE, UNH, Clermont-Ferrand, France.
² Institute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy, University of Leipzig, Deutscher Platz 5, 04103 Leipzig, Germany.
³ Center for Biotechnology and Biomedicine, University of Leipzig, Deutscher Platz 5, 04103 Leipzig, Germany.

No abstract available

Keywords: CE, cholesteryl ester; CVD, cardiovascular disease; LDL, low density lipoprotein; NFκB, nuclear factor kappa B; PC, phosphatidylcholine; PL, phospholipid; PPAR, peroxisome proliferator-activated receptor; PUFA, polyunsaturated fatty acid; TG, triglyceride; oxCE, oxidized CE; oxLDL, oxidized LDL; oxTG, oxidized TG.